Corticosteroids (Topical)

Low Potency Medium Potency
High Potency Very High Potency

Mechanism / Actions

Topical corticosteroids have anti-inflammatory, antipruritic and vasoconstrictive properties.

The mechanism of the anti-inflammatory activity of the topical steroids, in general, is unclear. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2.

Pharmacokinetics: The extent of percutaneous absorption of topical corticosteroids is determined by many factors including the vehicle and the integrity of the epidermal barrier. Occlusive dressings with hydrocortisone for up to 24 hours have not been demonstrated to increase penetration; however, occlusion of hydrocortisone for 96 hours markedly enhances penetration. Topical corticosteroids can be absorbed from normal intact skin. Inflammation and/or other disease processes in the skin may increase percutaneous absorption.

Low Potency   top of page icon

Aclometasone diproprionate  (Aclovate ®)

 Apply 2 to 3 times daily. [0.05% cream/ointment]

Desonide  (DesOwen ® )

Apply 2 to 3 times daily. [0.05% cream]

Flucinolone acetonide (Synalar ® )

Apply 2 to 4 times daily. [0.01% cream/solution]

Hydrocortisone  (Hytone ®, Cortaid ®, other):

Apply 3 to 4 times daily. [0.25%--liquid , 0.5%, 1%, 2.5%]

Medium Potency   top of page icon

Betamethasone dipropionate  (Diprosone ®)

 (Lotion 0.05%): apply once or twice daily.

betamethasone valerate:

Apply once or twice daily. [0.1% cream]

clocortolone pivalate (Cloderm ® )

Apply three times daily. [0.1% cream]

desoximetasone  (Topicort ® )

Apply 2 to 3 times daily. [0.05% cream]

fluocinolone acetonide  (Synalar ® )

Apply 2 to 4 times daily. [0.025% cream]

flurandrenolide  (Cordran ® )

Apply 2 to 3 times daily. [0.025% cream/05% cream/oint/lotion]

fluticasone propionate (Cutivate ® )

Apply once or twice daily. [0.05% cream, 0.005% oint]

Chydrocortisone butyrate  (Locoid ® )

Apply 2 to 3 times daily. [0.1% oint/soln]

hydrocortisone valerate  (Westcort ® )

Apply 2 to 3 times daily. [0.2% cream/oint]

mometasone furoate  (Elocon ® )

Apply once daily. [0.1% cream/oint/lotion]

prednicarbate  (Dermatop ® )

Apply twice daily. [0.1% cream]

triamcinolone (Aristocort ®, Kenalog ® )

Apply 3 to 4 times daily. [0.025%, 0.1% cream, otion.] 0.5% cream,oint, aerosol]

High Potency   top of page icon

amcinonide  (Cyclocort ® )

Apply 2 to 3 times daily. [0.1% cream/oint/lotion]

augmented betamethasone dipropionate (Diprolene ® )

Apply once or twice daily. [ 0.05% cream]

betamethasone dipropionate (Diprosone ® )

Apply once or twice daily. [0.05% cream,

desoximetasone (Topicort ® )

Apply twice daily. [0.25% cream/oint] [0.05% gel]

diflorasone diacetate (Maxiflor ®)

 Apply twice daily. [0.05% cream, oint]

fluocinolone acetonide (Synalar ® )

Apply 2 to 4 times daily. [0.2% cream]

fluocinonide  (Lidex ® )

Apply apply 2 to 4 times daily. [0.05% cream,oint,gel]

halcinonide  (Halog ® )

Apply apply 2 to 3 times daily. [0.1% nt]

Very High Potency   top of page icon

augmented betamethasone dipropionate (Diprolene ® )

Apply once or twice daily. [0.05% ointment]

clobetasol propionate (Temovate ® )

Apply twice daily. [0.05% cream, oint]

diflorasone diacetate  (Psorcon ®)

 Apply 1 to 3 times daily. [0.05% cream, oint]

halobetasol propionate (Ultravate ® )

Apply 2 to 3 times daily. [0.05% cream, oint]
 

Disclaimer

Listed dosages are for - Adult patients ONLY. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. GlobalRPH does not directly or indirectly practice medicine or provide medical services and therefore assumes no liability whatsoever of any kind for the information and data accessed through the Service or for any diagnosis or treatment made in reliance thereon.

David F. McAuley, Pharm.D., R.Ph.  GlobalRPh Inc.